Im Vordergrund ist auf dem Foto eine Stechmücke zu sehen, die sich in einem weißen Käfig befindet. Im Hintergrund sind weitere Stechmücken.

©BNITM | Dino Schachten

Publication

Addressing malaria drug resistance with novel combination therapies

BNITM researchers conducted a Phase II clinical trial with new drug combinations in Gabon and Ghana in cases of uncomplicated malaria. The result: the new drug combinations prove safe, well tolerated, and effective. The findings were recently published in the journal Lancet Microbe.

Learn more

©Solomon Kifle

Event

World NTD Day 2026: Art, discussion and global health

Many neglected tropical diseases could be prevented or treated, yet they remain a reality for millions of people worldwide. To mark World NTD Day, BNITM invited to an evening event in Hamburg’s Speicherstadt on 30 January 2026. A panel discussion with experts and an accompanying art exhibition explored the causes, consequences and social perception of neglected tropical diseases.

Learn more

The photo shows several children sitting at tables in the course room and looking into microscopes.

©BNITM

Event

Youth Future Day 🏳️‍🌈

What do researchers actually do all day? You are at least 11 years old and curious about science? Then join us for Youth Future Day on 12 March 2026 at BNITM!

Learn more

©BNITM

Funding

Greater safety through knowledge transfer

BNITM received approximately €1.2 million in funding from the Federal Foreign Office for international biosafety projects in Moldova, Ukraine and the Western Balkans. In close collaboration with local partners, the institute improved diagnostic methods, conducted seroprevalence studies and strengthened protection against the misuse of dangerous pathogens.

Learn more

Graphic: Model of balancing selection between the malaria parasite and the host, driving selection for autoimmune traits.

©Hopp

Research funding

ERC grant for malaria and autoimmune research

Dr Christine Hopp, junior research group leader at BNITM, receives an ERC Consolidator Grant for her AUTOIMMPRINT project. Her hypothesis: mild autoimmunity appears to have a natural protective function against malaria. The aim is to gain a more detailed understanding of this relationship at the molecular and cellular level – for more effective vaccines and new therapies. The research is being conducted at BNITM and in Mali and Ghana.

Learn more

Graphic on the Stages of the Map-Xing study

©Samuel Pazicky et al., published in Nature Microbiology

Publication

Fundamental research into malaria

The proteome-wide profiling method MAP-X shows in unprecedented detail how proteins of the malaria parasite interact at different stages of development. The technology combines thermal proteome profiling with machine learning and reveals previously unknown complexes. This creates new insights into key biological processes and provides starting points for future therapies – even beyond malaria.

Learn more